Recovery
SoftWave TRT Shockwave Device
Overview
The 78 overall score reflects strong safety (90) as a noninvasive FDA-cleared device with minimal risks, balanced by solid effectiveness (75) from meta-analyses (e.g., ESWT reduces MSK pain vs. controls, IIEF +3 points in ED RCTs) and adequate quality (70). Specific SoftWave RCT showed IIEF gains (P=0.02) at 0.12 mJ/mm², 3000-5000 shocks over 6 sessions. For recovery, meta-analysis of 632 patients confirmed better pain relief (P<0.05) than other therapies. Scores tempered by off-label ED use (no
Key strengths
- FDA-cleared for pain relief, tissue activation, ulcers/burns; noninvasive with quick sessions (10-15 min)
- Meta-analysis evidence for MSK recovery (pain MD improvement) and ED (IIEF +3 points)
- Broad coverage, deeper penetration than radial devices; faster healing per studies
Our analysis
Good option for recovery in FDA-cleared indications like MSK pain and wounds, backed by meta-analyses. Promising for ED off-label with specific SoftWave evidence. Consult provider for suitability given cost.
Frequently asked questions
- Is SoftWave TRT Shockwave Device worth buying?
- SoftWave TRT Shockwave Device has a Verify Influencers trust score of 83/100 based on ingredient quality, clinical evidence, and third-party testing.
- What is the trust score for SoftWave TRT Shockwave Device?
- SoftWave TRT Shockwave Device scored 83 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.
Browse all scored products · How products are scored